Latest news
FDA Approves Replimune Skin Cancer Drug After Rejections - MedscapeMedscape · Fri, 07 Aug 2026 13:27:22 GMTReplimune's Rollercoaster: From Double Rejection to FDA Panel Endorsement - AD HOC NEWSAD HOC NEWS · Tue, 04 Aug 2026 04:23:08 GMTFDA Advisory Committee Backs RP1 for Advanced Melanoma - Cure TodayCure Today · Sun, 02 Aug 2026 14:37:01 GMTFDA Advisory Panel Backs Replimune's Melanoma Drug - MedscapeMedscape · Fri, 31 Jul 2026 15:17:18 GMTReplimune Shares Take Flight Premarket After FDA Panel Backs RP1 - MoomooMoomoo · Fri, 31 Jul 2026 07:00:00 GMTReplimune surges after FDA advisers back skin cancer drug - ReutersReuters · Fri, 31 Jul 2026 07:00:00 GMTBreaking: US FDA Panel Backs Replimune’s Melanoma Drug - The Dermatology DigestThe Dermatology Digest · Thu, 30 Jul 2026 22:16:52 GMTUpdated: Replimune scores win as FDA advisors back melanoma treatment, bucking staff concerns - Endpoints NewsEndpoints News · Thu, 30 Jul 2026 22:01:57 GMT